JournalofSurgicalOncologyAdjuvantImatinibTreatmentafterR0ResectionforPatientsWithHigh-RiskGastrointestinalStromalTumors:AMedianFollow-Upof44M...
Certificate of AnalysisProductName:Product Name:ImatinibMesylateImatinib MesylateFormula:MolWeight:CAS No.:Cat. No.:Batch No:Test Date:Retest Date:C30H35N7O...
Case Report510Imatinib-Induced Tumor Lysis Syndrome: Report of a Caseand Review of the LiteratureHung Chang, MD; Lee-Yung ...
...apy and conventional chemo-therapy (2). No effective medical treatment was available until2001 when imatinib mesylate (Gleevec®) was successfullyintroduced to treat advanced unresectable GISTs (3). Thede...
...d tyrosine kinase inhi-bition as a model for cancer-drug discovery and therapy in general. In 2001, imatinib became the first such tyrosine kinase inhibi-tor therapy to be approved by the Food and Drug Admini...
...e-inhibitor Involving Regimen for Promyelocytic Blast Crisis of Chronic Myelogenous Leukemia During Imatinib Treatment with RT-PCR and FISH AnalysisRunning titleDasatinib for Promyelocytic Blast Crisis of CML...
...s with Philadelphia chromosome–positive chronic myelogenouspppygleukemia in chronic phase following imatinib resistance and intolerance Blood November 15, 2007vol. 110 no. 103540-3546[3]. Sevinc A.Activity of...
...rotein Tyrosine Kinase/RTK; Target:Bcr-AblBiological Activity:Flumatinib (HHGV678) ,a derivative of imatinib, is a multikinase inhibitor with IC50 Values of 1.2Flumatinib(HH-GV-678)aderivativeofimatinib,isamu...
337 论著 伊马替尼耐药的K562细胞系的建立及其生物学特性研究齐静 彭晖 顾振纶 梁中琴 杨纯正 【摘要】 目的 体外建立一株对伊马替尼(imatinib)耐药的白血病细胞并阐明其生物学特性。方法 以药物浓度递增的方法诱导人白血病细胞株K562对伊马替尼产生耐药性,以MTT法确定其耐药倍数及抗药谱。用RT2PCR和Westernblot方法检测耐药细胞...
...)属于多能造血干细胞恶性骨髓增生性疾病,费城(Ph)染色体是CML的细胞遗传学标志,90%以上CML患者骨髓细胞中发现有Ph染色体。经过20年的研究,CML患者的生存预后得到显著改善,特别是伊马替尼(imatinib,商品名格列卫)成功应用于临床治疗CML。伊马替尼是酪氨酸激酶抑制剂,目前是CML慢性期(CML CP)最有效的靶向治疗药物。2009年ASH年会上报告了伊马替尼用于CML一线治疗的IRIS研究(国...
...that far exceeds that expected from its frequency, and serves as a model disease for other cancers. Imatinib, an inhibitor of BCR-ABL tyrosine kinase, has revolutionised treatment of this disease, and is now ...